	Prospectos 1 44 1 9726,	
apareci 1 44 1 9724,	
""1612"" 1 44 1 8253,	
rosa 1 44 1 8245,	
241 1 44 1 8220,	
eu/ 1 44 1 8190,	
europa 1 44 1 8189,	
emea 1 44 1 8188,	
//www 1 44 1 8187,	
(EMEA) 1 44 1 8185,	
Medicamentos 1 44 1 8184,	
Europea 1 44 1 8182,	
web 1 44 1 8178,	
página 1 44 1 8177,	
TEXTO 1 44 1 8166,	
REVISIÓN 1 44 1 8164,	
Junio 1 44 1 8157,	
AUTORIZACIÓN/RENOVACIÓN 1 44 1 8151,	
FECHA 2 44 2 8147,8161,	
EU/1/06/343/001 1 44 1 8143,	
EU/1/06/343/006 1 44 1 8142,	
EU/1/06/343/003 1 44 1 8140,	
NÚMERO(S) 1 44 1 8135,	
Unido 1 44 1 8133,	
Reino 1 44 1 8132,	
1DH 1 44 1 8131,	
Road 1 44 1 8128,	
Sanderson 1 44 1 8127,	
Uxbridge 2 44 2 8124,8129,	
PHARMA 1 44 1 8122,	
SQUIBB 1 44 1 8121,	
COMERCIALIZACIÓN 2 44 2 8119,8139,	
AUTORIZACIÓN 3 44 3 8117,8137,8154,	
LA 4 44 4 8116,8149,8153,8163,	
TITULAR 1 44 1 8114,	
normativa 1 44 1 8111,	
acuerdo 1 44 1 8108,	
realizará 1 44 1 8106,	
contacto 1 44 1 8102,	
materiales 1 44 1 8097,	
utilizado 1 44 1 8092,	
tamaños 1 44 1 8076,	
comercializados 1 44 1 8074,	
Puede 1 44 1 8070,	
polipropileno 1 44 1 8053,	
cierre 1 44 1 8051,	
(HDPE) 1 44 1 8049,	
densidad 1 44 1 8048,	
polietileno 1 44 1 8045,	
90 1 44 1 8018,	
perforadas 2 44 2 8010,8035,	
unitarias 2 44 2 8009,8034,	
Alu/Alu 2 44 2 8006,8031,	
blíster 2 44 2 8004,8029,	
láminas 2 44 2 8003,8028,	
película; 2 44 2 7999,8024,	
Cada 2 44 2 7990,8065,	
contenido 1 44 1 7987,	
cerrado 1 44 1 7982,	
frasco 2 44 2 7980,8069,	
Mantener 1 44 1 7978,	
25°C 1 44 1 7977,	
Frasco 3 44 3 7970,8043,8144,	
temperatura 2 44 2 7961,7974,	
Blíster 1 44 1 7957,	
conservación 1 44 1 7956,	
Precauciones 2 44 2 7953,8081,	
procede 1 44 1 7943,	
Polisorbato 1 44 1 7936,	
Macrogol 1 44 1 7934,	
titanio 1 44 1 7932,	
Dióxido 1 44 1 7930,	
pelicular 1 44 1 7929,	
Cubierta 1 44 1 7928,	
Povidona 1 44 1 7927,	
Celulosa 1 44 1 7925,	
Estearato 1 44 1 7922,	
monohidratada 1 44 1 7921,	
Crospovidona 1 44 1 7919,	
Núcleo 1 44 1 7916,	
	6 1 44 1 7911,	
FARMACÉUTICOS 1 44 1 7910,	
http 1 44 1 8186,	
conoce 1 44 1 7907,	
observaciones 1 44 1 7899,	
predictivo 1 44 1 7896,	
precisión 1 44 1 7893,	
establecidos 1 44 1 7891,	
pudieron 1 44 1 7889,	
adenomas 1 44 1 7871,	
hepáticos 2 44 2 7860,7874,	
carcinomas 2 44 2 7859,7873,	
macho/hembras 1 44 1 7858,	
cerebrales 1 44 1 7855,	
especie 1 44 1 7841,	
específico 1 44 1 7838,	
observados 1 44 1 7832,	
patogenia 1 44 1 7827,	
clave 1 44 1 7824,	
evento 1 44 1 7823,	
pulmón 1 44 1 7809,	
validez 1 44 1 7948,	
proliferación 1 44 1 7804,	
precedido 1 44 1 7801,	
hayan 1 44 1 8099,	
estuvo 1 44 1 7800,	
tumores 5 44 5 7776,7799,7830,7851,7864,	
carcinogenicidad 1 44 1 7762,	
Estudios 1 44 1 7760,	
considerablemente 1 44 1 7748,	
clastogénico 1 44 1 7740,	
reparación 1 44 1 7730,	
micronúcleos 1 44 1 7728,	
sirio 1 44 1 7725,	
embrionarias 1 44 1 7722,	
transformación 1 44 1 7719,	
mamífero 1 44 1 7718,	
microbiana 1 44 1 7713,	
mutagenicidad 2 44 2 7712,7714,	
Ames 1 44 1 7710,	
genotoxicidad 1 44 1 7701,	
demostró 1 44 1 7682,	
mg/kg 1 44 1 7680,	
lactantes 1 44 1 7675,	
progenie 1 44 1 7661,	
peri-postnatal 1 44 1 7651,	
13ª 1 44 1 7644,	
costillas 1 44 1 7620,	
lumbares 1 44 1 7618,	
vértebras 1 44 1 7617,	
(vértebras 1 44 1 7610,	
reducida 2 44 2 7609,7634,	
osificación 2 44 2 7608,7633,	
malformaciones 1 44 1 7602,	
fetal 2 44 2 7601,7685,	
(resorciones) 2 44 2 7597,7632,	
embriofetal 2 44 2 7596,7631,	
maternal 1 44 1 7594,	
gestantes 1 44 1 7561,	
conejos 2 44 2 7560,7623,	
evidentes 1 44 1 7548,	
roedores 1 44 1 7532,	
seminíferos) 1 44 1 7522,	
túbulos 1 44 1 7521,	
(degeneración 1 44 1 7518,	
hembra 3 44 3 7510,7869,7877,	
macho 3 44 3 7508,7768,7863,	
ratas 9 44 9 7507,7558,7586,7653,7673,7734,7816,7857,7876,	
reproducción 1 44 1 7483,	
diariamente 1 44 1 7465,	
administró 3 44 3 7463,7488,7670,	
monos 3 44 3 7458,7556,7819,	
especies 1 44 1 7455,	
respectivamente) 1 44 1 7440,	
19 1 44 1 7424,	
exposiciones 9 44 9 7423,7470,7513,7536,7578,7589,7626,7779,7880,	
estableció 1 44 1 7415,	
central 1 44 1 7410,	
toxicología 3 44 3 7395,7480,7527,	
preclínicos 1 44 1 7389,	
etnias 1 44 1 7384,	
estudiaron 1 44 1 7379,	
asiáticos 1 44 1 7374,	
caucásicos 1 44 1 7372,	
aplicarse 1 44 1 7368,	
conclusiones 1 44 1 7365,	
origen 1 44 1 7349,	
influya 2 44 2 7333,7355,	
identificó 2 44 2 7325,7347,	
poblacional 2 44 2 7310,7345,	
farmacocinético 3 44 3 7309,7331,7344,	
29% 1 44 1 7261,	
29 1 44 1 7250,	
jóvenes 3 44 3 7235,7268,7306,	
varones) 2 44 2 7232,7256,	
74 1 44 1 7230,	
(edad 2 44 2 7222,7246,	
83 1 44 1 7220,	
ancianos 3 44 3 7211,7264,7298,	
sujetos 4 44 4 7210,7234,7267,7381,	
comparando 1 44 1 7209,	
evaluó 1 44 1 7198,	
sexos 1 44 1 7195,	
hombres 1 44 1 7164,	
contribuyó 1 44 1 7138,	
alterada 1 44 1 7137,	
Post-trasplante 1 44 1 7093,	
(19 1 44 1 7090,	
5) 1 44 1 7089,	
(16 1 44 1 7088,	
(62 1 44 1 7082,	
(153 1 44 1 7080,	
35 1 44 1 7077,	
226 1 44 1 7071,	
588 1 44 1 7067,	
CLT/F 1 44 1 7066,	
(SD) 2 44 2 7065,7092,	
(10 1 44 1 7063,	
(31 1 44 1 7061,	
(78 1 44 1 7059,	
(101 1 44 1 7057,	
NA 2 44 2 7054,7055,	
135 1 44 1 7050,	
197 1 44 1 7048,	
383 1 44 1 7046,	
CLR 1 44 1 7045,	
(CV) 1 44 1 7044,	
/ml) 1 44 1 7043,	
(ng·h 1 44 1 7042,	
AUC(0-T) 1 44 1 7041,	
51 1 44 1 7031,	
(29 2 44 2 7027,7086,	
(56 1 44 1 7025,	
(37 1 44 1 7019,	
7) 4 44 4 7018,7022,7028,7081,	
(30 1 44 1 7017,	
(CV%) 1 44 1 7016,	
(ng/ml) 1 44 1 7003,	
Grave 3 44 3 6999,7000,7001,	
Moderado 1 44 1 6998,	
afectado 1 44 1 6996,	
farmacocinética 4 44 4 6973,7206,7337,7359,	
6) 3 44 3 7062,7083,7091,	
muestra 1 44 1 6971,	
Diálisis 1 44 1 6956,	
eliminó 2 44 2 6947,6962,	
Un 1 44 1 6940,	
moderada 1 44 1 6913,	
farmacocinéticos 1 44 1 6907,	
alrededor 1 44 1 6899,	
efectiva 1 44 1 6897,	
128 1 44 1 6872,	
terminal 1 44 1 6870,	
eliminación 3 44 3 6869,8084,8088,	
233 1 44 1 7037,	
biexponencial 1 44 1 6864,	
manera 1 44 1 6863,	
descendieron 1 44 1 6861,	
máximos 1 44 1 6855,	
neta 1 44 1 6849,	
glomerular 1 44 1 6845,	
sufre 1 44 1 6843,	
	BRISTOL-MYERS 1 44 1 8120,	
471 1 44 1 6835,	
360 1 44 1 6833,	
oscila 1 44 1 6831,	
independiente 2 44 2 6826,7665,	
aproximadamente 1 44 1 6816,	
orina 1 44 1 6809,	
recuperación 1 44 1 6804,	
Eliminación 1 44 1 6794,	
glucuronidados 1 44 1 6791,	
II 1 44 1 6790,	
fase 1 44 1 6789,	
conjugados 1 44 1 6787,	
acetilados 1 44 1 6779,	
oxidativos 1 44 1 6777,	
metabolitos 2 44 2 6776,6786,	
C14 1 44 1 6772,	
marcado 1 44 1 6770,	
Tras 1 44 1 6765,	
enzimático 1 44 1 6763,	
original 1 44 1 7969,	
13% 2 44 2 6751,6948,	
vitro 1 44 1 6749,	
in 1 44 1 6748,	
magnesio 1 44 1 7924,	
proteínas 1 44 1 6745,	
agua 1 44 1 6739,	
excede 1 44 1 6737,	
volumen 1 44 1 6731,	
Distribución 1 44 1 6729,	
afectar 1 44 1 6716,	
relevante 1 44 1 6703,	
consideró 1 44 1 6701,	
administra 1 44 1 6696,	
20% 1 44 1 6685,	
44 1 44 1 6673,	
ayunas) 1 44 1 6666,	
retraso 1 44 1 6648,	
dio 1 44 1 6644,	
g 2 44 2 6630,6641,	
54 1 44 1 6628,	
sulfatados 1 44 1 6793,	
kcal 2 44 2 6627,6638,	
comida 2 44 2 6621,6635,	
cola 1 44 1 7607,	
indistintamente 1 44 1 6610,	
usarse 1 44 1 6609,	
farmacéuticas 1 44 1 6607,	
demostraron 1 44 1 6597,	
alcanzan 2 44 2 6583,7755,	
respectivamente 2 44 2 6574,6590,	
ng/ml 2 44 2 6573,6589,	
aproximada 1 44 1 6547,	
acumulación 3 44 3 6546,6879,6896,	
alcanza 2 44 2 6531,6815,	
estacionario 2 44 2 6529,6559,	
perivascular 1 44 1 7404,	
repetida 1 44 1 6516,	
AUC 6 44 6 6512,6681,6691,7155,7258,7295,	
Cmáx 5 44 5 6510,6553,6671,6689,7002,	
proporcional 1 44 1 6502,	
estimado 2 44 2 6489,6734,	
inalterado 2 44 2 6486,6807,	
EEIG 1 44 1 8123,	
fármaco 3 44 3 6485,6806,6881,	
urinaria 1 44 1 6483,	
absoluta 1 44 1 6474,	
máximas 1 44 1 6463,	
plasmáticas 2 44 2 6462,6858,	
alcanzando 1 44 1 6460,	
rápidamente 1 44 1 6459,	
Absorción 1 44 1 6455,	
especificado 1 44 1 6450,	
año; 1 44 1 6445,	
entecavir-lamivudine 1 44 1 6334,	
(16%) 1 44 1 6316,	
13 3 44 3 6315,6339,6841,	
(10%) 1 44 1 6314,	
(8%) 1 44 1 6290,	
80 3 44 3 6282,6352,7937,	
187 1 44 1 6280,	
resume 1 44 1 6254,	
bajo) 1 44 1 6235,	
12 3 44 3 6228,6289,7300,	
(aumento 1 44 1 6226,	
rebote 2 44 2 6224,6446,	
Hasta 1 44 1 6214,	
baja 1 44 1 6207,	
existir 1 44 1 6205,	
seleccionar 1 44 1 6197,	
indicando 2 44 2 6189,7820,	
monitorizado 1 44 1 6186,	
refractarios 1 44 1 6174,	
(5%) 1 44 1 6172,	
10/187 1 44 1 6171,	
procedentes 1 44 1 6169,	
nivel 1 44 1 6165,	
ventana 2 44 2 6156,6439,	
sucesivas 2 44 2 6150,6433,	
confirmado 2 44 2 6147,6430,	
d 2 44 2 6146,6412,	
determinado 3 44 3 6143,6427,6478,	
punto 3 44 3 6135,6233,6419,	
Incremento 2 44 2 6129,6413,	
(3er 2 44 2 6120,6403,	
156 2 44 2 6119,6402,	
testiculares 2 44 2 7517,7547,	
año) 4 44 4 6111,6121,6394,6404,	
(22 1 44 1 7021,	
(2º 2 44 2 6110,6393,	
102 4 44 4 6109,6116,6392,6399,	
año); 2 44 2 6102,6385,	
(1er 2 44 2 6101,6384,	
58 4 44 4 6100,6106,6383,6389,	
Incluidos 2 44 2 6077,6360,	
plazo) 2 44 2 6065,6348,	
(seguidas 2 44 2 6058,6341,	
entecavir-lamivudina 1 44 1 6051,	
147 1 44 1 6042,	
virológico 3 44 3 6015,6225,6307,	
cantidades 1 44 1 6782,	
Rebote 2 44 2 6014,6306,	
acumulativa 2 44 2 6002,6297,	
Probabilidad 2 44 2 6001,6296,	
Genotípica 5 44 5 5999,6012,6263,6294,6304,	
ETVr 7 44 7 5998,6011,6020,6293,6303,6318,6441,	
1%) 3 44 3 5991,5994,5997,	
149 4 44 4 5984,6044,6069,6874,	
278 1 44 1 5983,	
663 1 44 1 5982,	
(33 1 44 1 7023,	
Emergente 6 44 6 5964,6000,6013,6264,6295,6305,	
(ETVr)Genotípica 1 44 1 5963,	
rtL180M) 1 44 1 5959,	
(rtM204 1 44 1 5957,	
alteración 1 44 1 7502,	
presencia 1 44 1 5947,	
similares 1 44 1 6917,	
Estas 1 44 1 5941,	
tabla) 1 44 1 5940,	
genotípicas 1 44 1 5912,	
evidencias 1 44 1 5911,	
identificaron 1 44 1 5910,	
determinación 3 44 3 5887,6083,6366,	
había 2 44 2 5881,6185,	
lamivudina) 1 44 1 5876,	
(resistentes 1 44 1 5874,	
nucleósidos) 1 44 1 5869,	
(sin 2 44 2 5865,6985,	
monitorizó 1 44 1 5848,	
(048) 1 44 1 5817,	
abierto 1 44 1 5816,	
marcha 1 44 1 5812,	
actualmente 1 44 1 5809,	
posible 1 44 1 5794,	
futuros 1 44 1 5777,	
elección 1 44 1 5774,	
consecuencias 1 44 1 5771,	
mutante 1 44 1 5764,	
selección 1 44 1 5762,	
monoterapia 1 44 1 5752,	
reducciones 1 44 1 5736,	
37% 1 44 1 5688,	
produjo 1 44 1 5685,	
inicialmente 2 44 2 5655,5856,	
incremento 2 44 2 5646,6501,	
adicional 1 44 1 5612,	
seguido 1 44 1 5608,	
17) 1 44 1 5604,	
placebo 1 44 1 5601,	
grupos 2 44 2 5586,7371,	
11 3 44 3 5579,5649,6287,	
(solo 1 44 1 5560,	
incluyeron 1 44 1 5521,	
incluía 1 44 1 5515,	
seguían 1 44 1 5510,	
recurrente 1 44 1 5506,	
(ARN 1 44 1 5497,	
estable 2 44 2 5494,7113,	
costilla 1 44 1 7645,	
controlado 1 44 1 5491,	
negativo 1 44 1 5484,	
67 1 44 1 5476,	
alterados 1 44 1 5695,	
reciben 2 44 2 5468,7110,	
Poblaciones 1 44 1 5461,	
Edad/Sexo 1 44 1 5427,	
40% 1 44 1 5397,	
77 1 44 1 5380,	
17% 1 44 1 5372,	
221 1 44 1 7039,	
30% 1 44 1 5353,	
considerable 1 44 1 5317,	
(79/253) 1 44 1 5300,	
(131/286) 1 44 1 5289,	
46% 2 44 2 5288,6675,	
027 1 44 1 5283,	
(68/93) 1 44 1 5271,	
73% 1 44 1 5270,	
respondieron 4 44 4 5265,5275,5294,5305,	
madres 1 44 1 7576,	
(83/111) 1 44 1 5260,	
75% 2 44 2 5259,6818,	
período 3 44 3 5250,6155,6438,	
022 1 44 1 5245,	
mantuvo 2 44 2 5241,5285,	
protocolo 1 44 1 5237,	
definidos 1 44 1 5234,	
cumplieron 1 44 1 5229,	
única 2 44 2 6888,6979,	
27% 1 44 1 5210,	
64% 1 44 1 5174,	
28 1 44 1 5153,	
26 3 44 3 5146,7537,8155,	
De 2 44 2 5144,5378,	
84% 1 44 1 5129,	
77% 1 44 1 5116,	
325) 1 44 1 5087,	
14% 1 44 1 7158,	
normalizó 3 44 3 5045,5198,5413,	
164 1 44 1 5024,	
243 1 44 1 5014,	
81% 2 44 2 5011,5419,	
semanas) 3 44 3 5009,5164,5395,	
extensión 2 44 2 6075,6358,	
(media 3 44 3 5006,5161,5392,	
52 3 44 3 5005,5160,5391,	
superando 3 44 3 5001,5157,5388,	
finalizar 1 44 1 4990,	
(3% 1 44 1 4983,	
355) 1 44 1 4944,	
HBsAg) 2 44 2 4936,4988,	
(5% 1 44 1 4931,	
31% 2 44 2 4918,5299,	
normalización 6 44 6 4914,4966,5110,5132,5367,5680,	
87% 1 44 1 4911,	
80% 1 44 1 4900,	
consiguió 3 44 3 4894,5088,5347,	
354) 1 44 1 4893,	
alternativo 1 44 1 4869,	
presentaron 4 44 4 4860,5029,5180,5398,	
siguieron 1 44 1 4827,	
respondían 1 44 1 4825,	
negativos) 1 44 1 4821,	
MEq/ml) 1 44 1 4801,	
(ADN 1 44 1 4795,	
segundo 1 44 1 4782,	
semana 15 44 15 4776,5004,5159,5390,5896,5967,6095,6105,6115,6216,6246,6267,6378,6388,6398,	
ratones 4 44 4 7767,7835,7862,7868,	
pre-establecidos 1 44 1 4772,	
criterios 4 44 4 4769,4787,4839,5231,	
Resultados 1 44 1 4753,	
3% 2 44 2 4710,6965,	
61%* 1 44 1 4704,	
19%* 1 44 1 4689,	
-0 1 44 1 4681,	
11* 1 44 1 4680,	
perdieron 1 44 1 5322,	
145 2 44 2 4673,7035,	
141 1 44 1 4672,	
26% 2 44 2 4669,4970,	
16% 1 44 1 4661,	
34% 1 44 1 4660,	
28% 1 44 1 4652,	
Resistentes 1 44 1 4645,	
145) 1 44 1 4633,	
100 3 44 3 4625,7073,7471,	
141) 2 44 2 4620,5346,	
lavado 1 44 1 4615,	
periodos 1 44 1 4613,	
cambiaron 1 44 1 4603,	
posteriores 1 44 1 4754,	
entrar 1 44 1 4598,	
presentaba 1 44 1 4587,	
85% 2 44 2 4583,5364,	
026) 2 44 2 4578,5333,	
aleatorizado 2 44 2 4565,5815,	
cuantificación 2 44 2 4552,4749,	
inferior 2 44 2 4550,4747,	
Amplicor 2 44 2 4547,4744,	
Cobas 2 44 2 4546,4743,	
Roche 2 44 2 4545,4742,	
Ensayo 2 44 2 4544,4741,	
c 10 44 10 4543,4740,5988,6010,6018,6122,6286,6302,6317,6405,	
variable 2 44 2 4539,4736,	
b 4 44 4 4537,4734,6076,6359,	
(puntuación 2 44 2 4528,4725,	
evaluable 2 44 2 4527,4724,	
p 2 44 2 4516,4713,	
*valor 2 44 2 4514,4711,	
21% 2 44 2 4512,5219,	
Seroconversión 2 44 2 4510,4707,	
LSN) 5 44 5 4509,4706,5052,5203,5416,	
continuaron 5 44 5 4622,4848,4997,5383,5574,	
71% 1 44 1 4508,	
60% 1 44 1 4506,	
68%* 1 44 1 4505,	
Normalización 2 44 2 4497,4696,	
PCR)c 2 44 2 4496,4695,	
300 12 44 12 4493,4554,4692,4751,4907,4959,5036,5101,5123,5187,5360,5405,	
refieren 2 44 2 6029,6327,	
72% 1 44 1 4491,	
67%* 1 44 1 4488,	
indetectable 2 44 2 4487,4688,	
copias/ml)c 2 44 2 4483,4684,	
79% 2 44 2 4963,5055,	
-4 2 44 2 4480,5674,	
04* 1 44 1 4479,	
-5 3 44 3 4476,4478,4679,	
86* 1 44 1 4475,	
-6 1 44 1 4474,	
Reducción 2 44 2 4469,4674,	
325 1 44 1 4467,	
355 1 44 1 4466,	
354 1 44 1 4465,	
15% 3 44 3 4460,4705,6300,	
12% 1 44 1 4459,	
8% 2 44 2 4457,4709,	
Empeoramiento 2 44 2 4452,4662,	
38% 1 44 1 4451,	
36% 2 44 2 4450,4489,	
35% 2 44 2 4449,6301,	
39% 3 44 3 4448,4952,5021,	
61% 1 44 1 4440,	
70%* 1 44 1 4439,	
62% 1 44 1 4438,	
72%* 1 44 1 4437,	
histológicab 2 44 2 4436,4650,	
Mejora 4 44 4 4435,4441,4649,4653,	
296 1 44 1 4434,	
314 2 44 2 4432,4433,	
n 4 44 4 4431,4464,4648,4671,	
022) 2 44 2 4419,4880,	
(log10 2 44 2 4482,4683,	
(ensayo 6 44 6 4418,4424,4577,4879,5073,5332,	
(LVD) 1 44 1 4412,	
compara 2 44 2 4409,5825,	
(ETV) 1 44 1 4407,	
aleatorizados 1 44 1 4400,	
e 2 44 2 4369,6440,	
características 1 44 1 4359,	
Independientemente 1 44 1 4356,	
positivo 1 44 1 4355,	
copias/ml) 5 44 5 4345,4555,4752,5502,5651,	
400 3 44 3 4344,5501,7935,	
(semana 1 44 1 4338,	
log10 6 44 6 4327,5650,5676,6131,6229,6415,	
DNA 2 44 2 4322,4340,	
pronunciada 1 44 1 4304,	
incluyó 1 44 1 5474,	
mejora 1 44 1 4301,	
130 1 44 1 6067,	
alta 2 44 2 4288,8047,	
Una 1 44 1 4285,	
39 1 44 1 4477,	
(todos 1 44 1 4278,	
comparable 1 44 1 4265,	
igual 1 44 1 4258,	
índice 6 44 6 4253,4443,4454,4655,4664,6877,	
empeoramiento 1 44 1 4236,	
preñadas 1 44 1 7674,	
Knodell 6 44 6 4229,4246,4257,4296,4535,4732,	
027) 2 44 2 4425,5074,	
necroinflamatoria 4 44 4 4227,4294,4533,4730,	
309 1 44 1 7069,	
puntos 1 44 1 4223,	
633 1 44 1 4198,	
comparador 1 44 1 4194,	
serológica 2 44 2 4182,4845,	
bioquímica 2 44 2 4180,4847,	
beneficio 1 44 1 4171,	
tasa 3 44 3 4160,4333,4946,	
gliomas 1 44 1 7854,	
menor 1 44 1 4159,	
mutada 1 44 1 4153,	
unión 2 44 2 4144,6743,	
secuenciadas 1 44 1 4134,	
000 1 44 1 4130,	
modesto 1 44 1 4106,	
monosustituciones 1 44 1 4089,	
741 1 44 1 4081,	
16 4 44 4 4079,7014,7320,8145,	
disminuyen 1 44 1 4073,	
V) 1 44 1 4072,	
rtM250I 1 44 1 4069,	
I; 1 44 1 4067,	
disminución 1 44 1 6687,	
S; 1 44 1 4062,	
L 2 44 2 4059,4070,	
I 1 44 1 4058,	
G 2 44 2 4057,4065,	
(rtT184A 1 44 1 4054,	
observadas 1 44 1 4049,	
susceptibilidad 1 44 1 4041,	
adicionales 2 44 2 4026,7621,	
Datos 1 44 1 7388,	
rtL180M 1 44 1 4006,	
rtM204V 1 44 1 4004,	
(LVDr) 1 44 1 4000,	
cepa 1 44 1 3991,	
emtricitabina 2 44 2 3983,5522,	
seis 1 44 1 3973,	
antagonizó 1 44 1 3964,	
amplio 1 44 1 3947,	
anti-VHB 1 44 1 3942,	
antagonizaron 1 44 1 3939,	
zidovudina 1 44 1 3937,	
estavudina 1 44 1 3934,	
didanosina 1 44 1 3932,	
funcionales 1 44 1 3925,	
grasas 1 44 1 6625,	
sensibilidad 4 44 4 3915,4019,4075,4109,	
M184V 2 44 2 3910,5765,	
altas 2 44 2 3897,7512,	
presión 1 44 1 3894,	
confirmando 1 44 1 3892,	
M184I 1 44 1 3891,	
seleccionaron 1 44 1 3888,	
cultivos 7 44 7 3882,3929,3969,3986,4045,4164,7742,	
estudio 6 44 6 3880,6073,6356,7551,7648,7664,	
virales 1 44 1 3876,	
títulos 1 44 1 3875,	
resultado 1 44 1 3851,	
dió 1 44 1 3849,	
experimentales 1 44 1 3848,	
condiciones 1 44 1 3847,	
tipos 2 44 2 3843,7849,	
VIH-1 1 44 1 3840,	
aislados 3 44 3 3837,4052,6168,	
cepas 1 44 1 3833,	
panel 1 44 1 3831,	
inhibitoria 2 44 2 3825,3895,	
sensibles 1 44 1 3817,	
siguen 1 44 1 3815,	
neumocitos 1 44 1 7806,	
rtN236T 1 44 1 3812,	
recombinantes 1 44 1 3803,	
059 1 44 1 3799,	
010 1 44 1 3796,	
(rango 1 44 1 3794,	
026 2 44 2 3792,3860,	
rtM204V) 1 44 1 3789,	
(rtL180M 1 44 1 3787,	
reversible 1 44 1 7405,	
LVDr 5 44 5 3786,4589,5956,6128,6411,	
mutantes 2 44 2 3781,3903,	
EC50 3 44 3 3773,3854,3870,	
75 2 44 2 6663,7322,	
silvestre 3 44 3 3769,3992,4087,	
transfectadas 1 44 1 3763,	
humanas 2 44 2 3762,6747,	
004 1 44 1 3757,	
concentración 1 44 1 3754,	
EC50) 1 44 1 3751,	
50% 1 44 1 3750,	
(reducción 1 44 1 3748,	
Actividad 1 44 1 3738,	
sanos; 1 44 1 6602,	
160 1 44 1 3736,	
Conservar 1 44 1 7965,	
(Ki 1 44 1 3734,	
HepG2 2 44 2 3733,3761,	
células 5 44 5 3732,3760,3845,7716,7721,	
mitocondrial 1 44 1 3730,	
(1%) 1 44 1 6312,	
relevantes 1 44 1 3720,	
313 1 44 1 4468,	
Además 1 44 1 3710,	
µM 3 44 3 3709,3758,3793,	
ADN-polimerasas 1 44 1 3697,	
débil 1 44 1 3694,	
TP 1 44 1 3690,	
M 2 44 2 3688,4060,	
0012 1 44 1 3687,	
ADN- 1 44 1 3680,	
Ki 2 44 2 3675,3704,	
síntesis 3 44 3 3665,3727,3743,	
(3) 1 44 1 3664,	
pregenómico 1 44 1 3662,	
mensajero 1 44 1 3661,	
puntuación 2 44 2 4242,4286,	
ARN 2 44 2 3660,5739,	
partir 1 44 1 3658,	
(-) 1 44 1 3654,	
cadena 2 44 2 3653,3668,	
transcripción 1 44 1 3649,	
(2) 1 44 1 3648,	
grasas) 2 44 2 6632,6643,	
(priming) 1 44 1 3642,	
cebado 1 44 1 3641,	
(1) 1 44 1 3640,	
funcionalmente 1 44 1 3632,	
entecavir-TP 2 44 2 3630,3677,	
desoxiguanosina-TP 1 44 1 3629,	
natural 1 44 1 3628,	
Al 3 44 3 3623,4989,5527,	
intracelular 1 44 1 3619,	
semivida 3 44 3 3618,6867,6894,	
(TP) 1 44 1 3613,	
trifosfato 1 44 1 3612,	
efizcamente 1 44 1 3607,	
fosforila 1 44 1 3606,	
acción 1 44 1 3589,	
Mecanismo 1 44 1 3587,	
filtración 1 44 1 6844,	
J05AF10 1 44 1 3586,	
ATC 1 44 1 3585,	
Código 1 44 1 3584,	
inversa 5 44 5 3583,3650,3979,4010,4150,	
transcriptasa 4 44 4 3582,3978,4009,4149,	
inhibidores 2 44 2 3579,3974,	
nucleótidos 1 44 1 3578,	
primaria 2 44 2 4542,4739,	
farmacoterapéutico 1 44 1 3575,	
Grupo 2 44 2 3574,7340,	
farmacodinámicas 1 44 1 3573,	
conservar 2 44 2 7959,7972,	
Propiedades 2 44 2 3572,6453,	
	5 1 44 1 3570,	
ESTE 1 44 1 3568,	
FARMACOLÓGICAS 1 44 1 3566,	
PROPIEDADES 1 44 1 3565,	
estándar 2 44 2 3562,6622,	
soporte 1 44 1 3561,	
crónica) 1 44 1 6988,	
recurrir 1 44 1 3556,	
fuera 1 44 1 3554,	
hubiera 1 44 1 3549,	
producirse 1 44 1 3540,	
inesperadas 1 44 1 3536,	
40 4 44 4 3530,3708,7052,7244,	
únicas 1 44 1 3527,	
Periodo 1 44 1 7946,	
14 3 44 3 3523,6313,7385,	
tasas 3 44 3 4895,5089,5348,	
períodos 2 44 2 3520,7493,	
20 4 44 4 3517,5675,6056,7242,	
sanos 2 44 2 3513,7129,	
voluntarios 3 44 3 3512,6601,7128,	
sobredosis 2 44 2 3510,3542,	
ningún 1 44 1 3507,	
9 8 44 8 3501,4325,4463,7030,7038,7049,8027,8146,	
subcutáneo 1 44 1 3499,	
tejido 1 44 1 3498,	
piel 1 44 1 3495,	
rash 1 44 1 3491,	
conocida 1 44 1 3490,	
aprobación 1 44 1 3487,	
siguientes 2 44 2 3476,7706,	
identificado 1 44 1 3474,	
identificadas 1 44 1 3467,	
además 1 44 1 3459,	
años) 2 44 2 3406,5460,	
65 4 44 4 3405,5459,5642,7218,	
clínicos) 2 44 2 3396,5448,	
respecto 4 44 4 3386,3988,4084,4230,	
aparentes 2 44 2 3377,5431,	
hubo 4 44 4 3375,5429,7191,7499,	
Sexo/edad 1 44 1 3373,	
similar 1 44 1 3356,	
incluían 1 44 1 3353,	
corporal 3 44 3 6740,7189,7293,	
actividad) 1 44 1 3351,	
Naturaleza 1 44 1 7985,	
(tratamiento 1 44 1 3347,	
regímenes 3 44 3 3344,5518,5778,	
podría 2 44 2 3317,6715,	
independientemente 1 44 1 3302,	
interrumpe 1 44 1 3301,	
perfectamente 1 44 1 7981,	
priori 1 44 1 3296,	
definida 1 44 1 3294,	
interrumpió 2 44 2 3287,4764,	
hizo 1 44 1 3251,	
les 2 44 2 3250,4865,	
limitado 2 44 2 3243,3336,	
número 3 44 3 3242,3335,5316,	
sólo 4 44 4 3240,4103,5943,7366,	
notificaron 1 44 1 3225,	
24/28) 1 44 1 3223,	
(86% 1 44 1 3222,	
tratamiento]) 1 44 1 3182,	
final 6 44 6 3180,5192,5205,5424,6153,6436,	
medición 1 44 1 3178,	
última 1 44 1 3177,	
basal 7 44 7 3171,4287,4526,4529,4723,4726,6166,	
[nivel 1 44 1 3170,	
referencia 1 44 1 3169,	
10% 2 44 2 3145,4458,	
Sobredosis 1 44 1 3502,	
6% 2 44 2 3136,6299,	
recibido 1 44 1 3130,	
incluido 1 44 1 3114,	
interrumpido 1 44 1 3104,	
agudas 1 44 1 3097,	
monitorización 3 44 3 3078,5985,6283,	
coincidió 1 44 1 3068,	
viral 5 44 5 3061,3639,4473,4678,5633,	
carga 4 44 4 3060,4472,4677,5632,	
vertebrales 1 44 1 7603,	
continuaban 1 44 1 3042,	
resolvieron 1 44 1 3040,	
semanas; 1 44 1 3036,	
comienzo 2 44 2 3022,3205,	
recibían 1 44 1 5711,	
medio 2 44 2 3019,5554,	
frente 14 44 14 2957,3002,3828,3956,4192,4517,4714,5062,5114,5217,5268,5297,5643,6660,	
produjeron 2 44 2 2932,2977,	
3x 1 44 1 2810,	
4% 2 44 2 2803,2959,	
envases 1 44 1 8078,	
relacionados 2 44 2 2707,2911,	
aspectos 2 44 2 2706,2910,	
nuevos 2 44 2 2705,2909,	
distribución 1 44 1 6733,	
reveló 2 44 2 2704,2908,	
crónico 2 44 2 2693,2897,	
48 12 44 12 2689,2893,4185,4339,4395,4643,4682,4757,4777,5310,5671,6350,	
monoinfección 1 44 1 3366,	
000/mm3 2 44 2 2677,2881,	
plaquetas 2 44 2 2674,2878,	
038 1 44 1 5473,	
recuento 4 44 4 2672,2876,5553,5566,	
11% 4 44 4 2669,3004,3255,4668,	
amilasa 2 44 2 2645,2849,	
494 1 44 1 5558,	
(Límite 2 44 2 4549,4746,	
presenta 1 44 1 4157,	
g/dl 1 44 1 2636,	
albúmina 1 44 1 2632,	
90%* 1 44 1 4490,	
observaron 11 44 11 2629,2846,3872,5945,6158,6775,7515,7545,7656,7698,7770,	
LSN 8 44 8 2620,2792,2838,2941,2986,3161,4319,4817,	
146 1 44 1 6281,	
superiores 1 44 1 2608,	
Business 1 44 1 8125,	
valores 6 44 6 2602,3701,3852,3866,6508,6551,	
1% 7 44 7 2598,2639,2680,2817,2884,4690,5929,	
asoció 1 44 1 4298,	
inicial 12 44 12 2595,2610,2627,2651,2666,2813,2829,2844,2855,2870,2947,2992,	
elevaciones 2 44 2 2587,3312,	
5% 5 44 5 2585,3401,5454,6007,7301,	
(LSN) 1 44 1 2570,	
normal 3 44 3 2569,6926,7133,	
rango 7 44 7 2568,3857,3948,6521,7214,7238,7316,	
superior 5 44 5 2566,2687,2891,7962,7975,	
límite 1 44 1 2565,	
> 26 44 26 2561,2575,2590,2605,2616,2622,2646,2661,2789,2794,2809,2824,2835,2840,2850,2865,2937,2943,2982,2988,3163,3404,3735,3862,4812,5458,	
Incompatibilidades 1 44 1 7941,	
2% 10 44 10 2552,2654,2780,2858,2950,2995,4925,4977,6005,6009,	
(con 1 44 1 7434,	
Desviaciones 2 44 2 2542,2770,	
3er 2 44 2 6026,6324,	
significativamente 3 44 3 5637,7334,7356,	
supresión 1 44 1 4791,	
psiquiátricos 2 44 2 2541,2769,	
parámetro 2 44 2 7330,7353,	
insomnio 2 44 2 2539,2767,	
lugar 3 44 3 2534,2762,6645,	
alteraciones 2 44 2 2531,2759,	
gastrointestinales 2 44 2 2527,2755,	
dispepsia 2 44 2 2525,2753,	
diarrea 2 44 2 2523,2751,	
nervioso 3 44 3 2520,2748,7409,	
Trastornos 9 44 9 2517,2526,2528,2540,2745,2754,2756,2768,3492,	
53 2 44 2 2511,4481,	
global 1 44 1 4269,	
exposición 7 44 7 2495,2725,3712,7096,7126,7143,7684,	
25% 2 44 2 3390,5442,	
HBeAg) 1 44 1 2486,	
(positivos 1 44 1 2482,	
Experiencia 7 44 7 2474,2711,3321,3457,4166,4373,4556,	
intervalo 1 44 1 2471,	
decreciente 1 44 1 2465,	
orden 1 44 1 2464,	
1/100 1 44 1 2455,	
solapamiento 1 44 1 4617,	
1/10); 1 44 1 2452,	
micromolares 2 44 2 3885,3962,	
( 11 44 11 2451,2454,3389,3400,4501,4700,5199,5414,5441,5453,7790,	
frecuente 8 44 8 2450,2453,2513,2521,2538,2743,2749,2766,	
definen 1 44 1 2447,	
órganos 1 44 1 2441,	
clasificación 1 44 1 2439,	
sistema 5 44 5 2437,2519,2747,6762,7408,	
enumeran 2 44 2 2434,2462,	
(3%) 1 44 1 2418,	
(4%) 1 44 1 2415,	
mareos 2 44 2 2414,2515,	
(6%) 2 44 2 2413,6288,	
(9%) 1 44 1 2411,	
cefalea 3 44 3 2410,2514,2744,	
relacionadas 2 44 2 2406,2427,	
posiblemente 2 44 2 2405,2426,	
consideradas 2 44 2 2401,2422,	
gravedad 2 44 2 2399,2467,	
año 6 44 6 4783,6027,6325,6449,7468,7554,	
comparables 1 44 1 2391,	
resultados 8 44 8 2384,2545,2773,4275,4392,4640,6024,6322,	
desviaciones 1 44 1 2381,	
incluidas 1 44 1 2379,	
perfiles 1 44 1 2372,	
ciego 4 44 4 2367,4402,4567,4854,	
periodo 3 44 3 2359,5611,6941,	
183) 1 44 1 2351,	
679) 1 44 1 2345,	
Park 1 44 1 8126,	
= 16 44 16 2344,2350,2355,4553,4619,4632,4750,4892,4943,5048,5086,5142,5345,5598,5603,7120,	
(n 13 44 13 2343,2349,2354,4618,4631,4891,4942,5085,5141,5344,5597,5602,7119,	
mg/día 3 44 3 2342,2348,3518,	
recibieron 2 44 2 2336,3515,	
720 1 44 1 2330,	
total 4 44 4 2327,2615,2834,6741,	
cuatro 1 44 1 2320,	
evaluación 1 44 1 2312,	
Reacciones 1 44 1 2309,	
8 9 44 9 2308,3898,4015,5548,6584,6639,7004,7040,8134,	
alterar 1 44 1 2299,	
somnolencia 2 44 2 2292,2516,	
fatiga 2 44 2 2290,2412,	
hámster 1 44 1 7724,	
Mareos 1 44 1 2289,	
tenga 1 44 1 2284,	
espera 1 44 1 2282,	
farmacodinámico 1 44 1 2277,	
perfil 6 44 6 2276,2488,2718,3328,3358,3380,	
Basándose 2 44 2 2273,6479,	
realizado 2 44 2 2258,5882,	
máquinas 3 44 3 2254,2272,2306,	
55%* 1 44 1 4651,	
capacidad 3 44 3 2249,2267,2301,	
Efectos 1 44 1 2246,	
excreción 3 44 3 2227,6482,7690,	
materna 2 44 2 2217,2233,	
leche 3 44 3 2216,2232,7695,	
excreta 1 44 1 2213,	
neonato 1 44 1 2204,	
(-3 1 44 1 5641,	
contenían 1 44 1 3907,	
impedir 1 44 1 2200,	
apropiadas 1 44 1 2198,	
recurrirse 1 44 1 2194,	
nacido 1 44 1 2189,	
biodisponibilidad 2 44 2 6473,6492,	
terapia 4 44 4 3308,3559,6049,6332,	
recién 1 44 1 2188,	
madre 1 44 1 2186,	
eficaces 1 44 1 2170,	
anticonceptivos 1 44 1 2169,	
métodos 1 44 1 2168,	
utilizar 4 44 4 2167,2253,2271,2305,	
fértil 1 44 1 2165,	
feto 1 44 1 2160,	
desarrollo 3 44 3 2158,5795,7797,	
riesgos 1 44 1 2154,	
suspender 1 44 1 3090,	
conocen 1 44 1 2152,	
claramente 1 44 1 2146,	
embarazo 1 44 1 2142,	
humanos 9 44 9 2135,2219,7433,7476,7542,7584,7745,7785,7904,	
seres 1 44 1 2134,	
potencial 1 44 1 2132,	
elevadas 5 44 5 2123,7590,7627,7750,7881,	
reproductiva 1 44 1 2120,	
toxicidad 7 44 7 2119,3552,7444,7593,7595,7630,7650,	
mostrado 1 44 1 2118,	
estudios 10 44 10 2114,2221,2259,3924,3952,7393,7449,7478,7525,7707,	
18% 2 44 2 2873,4513,	
utilización 2 44 2 2107,3481,	
suficientes 2 44 2 2104,7380,	
lactancia 2 44 2 2100,2238,	
Embarazo 1 44 1 2098,	
CYP450 2 44 2 2095,6764,	
mediadas 1 44 1 2093,	
(> 2 44 2 3157,4289,	
medicamentosas 1 44 1 2092,	
produzcan 1 44 1 2090,	
improbable 1 44 1 2085,	
(CYP450) 1 44 1 2077,	
P450 1 44 1 2076,	
citocromo 1 44 1 2075,	
enzimas 1 44 1 2073,	
precedió 1 44 1 3065,	
inhibidor 4 44 4 2070,3693,4146,6758,	
inductor 2 44 2 2068,6760,	
sustrato 3 44 3 2067,3627,6757,	
(hioides) 1 44 1 7635,	
abacavir 1 44 1 3931,	
actúa 2 44 2 2065,6755,	
ambas 1 44 1 6605,	
farmacocinéticas 2 44 2 2055,6454,	
interacciones 2 44 2 2054,2091,	
(1 1 44 1 6653,	
posibles 1 44 1 2047,	
estrechamente 1 44 1 2041,	
vigilarse 2 44 2 2040,3544,	
tipo 2 44 2 2036,3768,	
coadministra 1 44 1 2033,	
Si 2 44 2 2030,3297,	
excretan 1 44 1 2019,	
efectos 5 44 5 2009,2262,3718,7573,7657,	
disoproxil 2 44 2 2002,5525,	
1x 1 44 1 5415,	
tenofovir 4 44 4 2001,2062,3935,5524,	
dipivoxil 1 44 1 1999,	
adefovir 4 44 4 1998,2060,3811,5834,	
excepción 1 44 1 1995,	
A 5 44 5 1994,4855,5308,5624,7116,	
séricas 2 44 2 1988,6746,	
tubular 2 44 2 1982,6848,	
secreción 2 44 2 1981,6847,	
ensayo 7 44 7 4564,4601,5244,5282,5472,5530,5814,	
compiten 1 44 1 1978,	
negativamente 1 44 1 1971,	
afectan 2 44 2 1970,2025,	
coadministración 2 44 2 1966,2012,	
riñón 2 44 2 1960,6801,	
predominantemente 2 44 2 1957,6798,	
elimina 2 44 2 1956,6797,	
Dado 2 44 2 1952,2148,	
interacción 2 44 2 1951,3927,	
formas 2 44 2 1949,6606,	
histológica 4 44 4 4178,4215,4302,4370,	
medicamentos 6 44 6 1946,1968,1993,2016,2038,9728,	
M; 1 44 1 3864,	
Interacción 1 44 1 1942,	
encuentra 1 44 1 1931,	
incorporación 1 44 1 4023,	
personas 1 44 1 1929,	
glucosa-galactosa 1 44 1 1921,	
malabsorción 1 44 1 1919,	
Lapp 1 44 1 1917,	
89% 1 44 1 5107,	
lactasa 1 44 1 1915,	
deficiencia 1 44 1 1913,	
galactosa 1 44 1 1912,	
intolerancia 1 44 1 1909,	
raros 1 44 1 1907,	
microcristalina 1 44 1 7926,	
hereditarios 1 44 1 1906,	
9) 1 44 1 7121,	
problemas 1 44 1 1905,	
Lactosa 2 44 2 1885,7920,	
2x 5 44 5 2795,2836,2841,2944,2989,	
oportunas 1 44 1 1884,	
medidas 5 44 5 1881,2197,4273,6149,6432,	
tomando 1 44 1 1879,	
seguir 1 44 1 1878,	
transmisión 2 44 2 1869,2181,	
especial 1 44 1 8086,	
positivos) 1 44 1 4809,	
reduzca 1 44 1 1865,	
demostrado 2 44 2 1859,2225,	
advertirse 1 44 1 1851,	
generales 3 44 3 1849,2529,2757,	
Aspectos 1 44 1 1848,	
células/mm3) 2 44 2 1847,5571,	
200 2 44 2 1846,5570,	
celulares 8 44 8 1843,3699,3883,3930,3970,3987,4046,4165,	
recuentos 1 44 1 1842,	
bajos 2 44 2 1841,3868,	
limitada 1 44 1 1833,	
dispone 2 44 2 1814,1830,	
No 14 44 14 1812,2050,2101,2171,2234,2255,3503,5428,6995,7543,7696,7942,7958,7971,	
régimen 5 44 5 1804,2365,4853,5512,5577,	
bioequivalencia 1 44 1 6599,	
coinfección 2 44 2 1797,5465,	
68 1 44 1 1794,	
µM) 2 44 2 3737,3800,	
estudiado 2 44 2 1764,1792,	
Entecavir 6 44 6 1760,2063,3689,5962,6261,7738,	
TARGA 9 44 9 1759,1805,3346,5470,5513,5519,5713,5754,5779,	
estén 2 44 2 1757,8073,	
3) 1 44 1 2127,	
utilizarse 3 44 3 1748,2139,5788,	
96 8 44 8 2701,2905,4889,5008,5083,5163,5342,5394,	
(TARGA) 1 44 1 1738,	
1/10) 1 44 1 2457,	
actividad 6 44 6 1737,3598,3824,3941,3954,3966,	
gran 2 44 2 1736,3350,	
utilizó 1 44 1 1715,	
observado 5 44 5 1706,2053,4116,5760,6882,	
efectivo 2 44 2 1700,5729,	
test 2 44 2 7708,7726,	
estaban 5 44 5 1696,1731,1801,5725,5748,	
evaluado 3 44 3 1688,2007,5718,	
antirretroviral 4 44 4 1683,1734,1788,3348,	
313) 1 44 1 5143,	
simultáneamente 6 44 6 1681,1698,1786,5469,5712,5727,	
2006 1 44 1 8159,	
recibiendo 8 44 8 1680,1697,1732,1758,1785,1802,5726,5749,	
VIH/VHB 10 44 10 1676,1693,1754,1782,1799,3341,5466,5708,5722,5746,	
coinfectados 12 44 12 1674,1691,1752,1780,1826,1836,3324,3339,5485,5706,5721,5744,	
infectados 2 44 2 1663,7106,	
27 1 44 1 7029,	
co- 1 44 1 1662,	
existen 2 44 2 1653,2102,	
D 2 44 2 1651,1672,	
C 4 44 4 1649,1670,4055,4064,	
Coinfección 1 44 1 1646,	
(945 1 44 1 6626,	
tacrolimus 2 44 2 1641,7118,	
acumulada 4 44 4 4898,4949,5092,5351,	
ciclosporina 2 44 2 1639,7115,	
minuciosamente 1 44 1 1622,	
presentan 3 44 3 4011,4390,4638,	
evaluarse 1 44 1 1621,	
receptores 3 44 3 1612,1632,7101,	
hay 2 44 2 1599,2172,	
69 3 44 3 2740,7033,7226,	
hepático 5 44 5 1598,1616,1636,7094,7105,	
trasplante 4 44 4 1597,1615,1635,7104,	
Blister 1 44 1 8141,	
esclarecido 1 44 1 1589,	
plazo 1 44 1 1582,	
(+) 1 44 1 3669,	
clínica 3 44 3 1579,4167,5842,	
importancia 1 44 1 1578,	
apareció 1 44 1 1565,	
presente 2 44 2 1557,9716,	
rtM250 5 44 5 1554,4033,4096,5925,9713,	
emergente 4 44 4 6021,6240,6319,6442,	
rtS202 6 44 6 1552,4031,4063,4094,5923,9711,	
derivada 2 44 2 1545,9704,	
previamente 4 44 4 1537,4309,4350,9696,	
respuestas 2 44 2 4177,4367,	
pequeño 2 44 2 1530,9689,	
envase 4 44 4 7968,7989,7991,8066,	
porcentaje 2 44 2 1529,9688,	
detectar 3 44 3 1525,2046,9684,	
tratar 1 44 1 1717,	
análisis 5 44 5 1522,3821,7308,7343,9681,	
realizarse 2 44 2 1521,9680,	
población 2 44 2 1505,9664,	
(ETVr) 7 44 7 1502,1544,5920,6163,6262,9661,9703,	
asociadas 2 44 2 1496,9655,	
doble 4 44 4 2366,4401,4566,6549,	
incluyendo 2 44 2 1494,9653,	
secundarias 2 44 2 1493,9652,	
(cirrosis) 1 44 1 4261,	
posterior 3 44 3 1489,5899,9648,	
conducir 5 44 5 1486,2251,2269,2303,9645,	
podrían 3 44 3 1485,2298,9644,	
Metabolismo 1 44 1 6752,	
sustituciones 14 44 14 1479,1492,1547,4003,4048,4120,5914,5942,5950,6159,6199,9638,9651,9706,	
codifican 2 44 2 1478,9637,	
polimerasa 7 44 7 1473,3602,3638,3645,3681,3723,9632,	
específica 2 44 2 1463,9622,	
analíticos 2 44 2 1454,9613,	
marcadores 2 44 2 1453,9612,	
mejoría 3 44 3 1450,4214,9609,	
cambios 5 44 5 1442,4025,7516,7546,9601,	
(INTIs) 1 44 1 3980,	
asegurarse 2 44 2 1438,9597,	
médicos 2 44 2 1436,9595,	
potencialmente 2 44 2 1429,9588,	
diferenciar 2 44 2 1416,9575,	
riguroso 2 44 2 1414,9573,	
F 1 44 1 4056,	
Estos 2 44 2 1409,9568,	
factores 2 44 2 1402,9561,	
u 2 44 2 1400,9559,	
obesas) 2 44 2 1396,9555,	
mujeres 9 44 9 1395,2111,2162,3392,5444,7161,7225,7249,9554,	
aminoácidos 1 44 1 4029,	
VIH 16 44 16 1703,1710,1728,1771,1828,1838,3326,3905,3958,5487,5496,5499,5732,5741,5767,5799,	
particular 2 44 2 1393,9552,	
prescriben 2 44 2 1384,9543,	
precaución 5 44 5 1381,1462,1883,9540,9621,	
actuarse 2 44 2 1379,9538,	
ofreció 1 44 1 4866,	
sérico 2 44 2 1377,9536,	
lactato 2 44 2 1376,9535,	
rtT184 5 44 5 1551,4030,4093,5922,9710,	
hepático/esteatosis 2 44 2 1369,9528,	
fallo 4 44 4 1368,1371,9527,9530,	
pancreatitis 2 44 2 1367,9526,	
asociaron 4 44 4 1365,3054,4330,9524,	
desenlace 2 44 2 1362,9521,	
veces 23 44 23 1360,2563,2577,2592,2607,2618,2624,2648,2663,3159,3165,4016,4082,4815,6885,7124,7427,7472,7538,7580,7781,7792,9519,	
indicar 2 44 2 1350,9509,	
abdominal 2 44 2 1348,9507,	
dolor 2 44 2 1347,9506,	
embriotoxicidad 1 44 1 7571,	
vómitos 4 44 4 1345,2522,2750,9504,	
vasculares 1 44 1 7865,	
benignos 3 44 3 1341,7866,9500,	
digestivos 2 44 2 1340,9499,	
etiología 2 44 2 1336,9495,	
metabólica/láctica 2 44 2 1334,9493,	
progresiva 2 44 2 1331,9490,	
log10/ml 1 44 1 3063,	
transaminasas 4 44 4 1329,1421,9488,9580,	
rápida 2 44 2 1326,9485,	
CD4 3 44 3 1844,5556,5568,	
observa 3 44 3 1323,6499,9482,	
Debe 4 44 4 1313,1378,9472,9537,	
descartarse 2 44 2 1310,9469,	
Como 2 44 2 1301,9460,	
análogos 6 44 6 1298,1318,1385,9457,9477,9544,	
78%* 1 44 1 4507,	
mortal 4 44 4 1285,1363,9444,9522,	
hipoxemia) 2 44 2 1282,9441,	
acidosis 8 44 8 1277,1333,1354,1433,9436,9492,9513,9592,	
grave 5 44 5 1269,1290,6915,9428,9449,	
hepatomegalia 8 44 8 1268,1289,1330,1398,9427,9448,9489,9557,	
administraba 1 44 1 7566,	
láctica 8 44 8 1266,1278,1355,1434,9425,9437,9514,9593,	
Acidosis 2 44 2 1265,9424,	
(379 1 44 1 6637,	
51) 1 44 1 5599,	
frecuencia 5 44 5 1264,2473,3488,6208,9423,	
PRIMERA 1 44 1 8150,	
apropiados 4 44 4 1261,1523,9420,9682,	
controles 2 44 2 1260,9419,	
someterse 2 44 2 1257,9416,	
peso 5 44 5 7175,7188,7280,7292,7600,	
finalizado 2 44 2 1253,9412,	
nucleósido 3 44 3 1307,3593,9466,	
síntomas 4 44 4 1243,1339,9402,9498,	
presenten 2 44 2 1242,9401,	
interrumpa 2 44 2 1226,9385,	
funciones 2 44 2 1209,9368,	
asociados 4 44 4 1203,1286,9362,9445,	
serológicos 2 44 2 1202,9361,	
virológicos 2 44 2 1200,9359,	
parámetros 3 44 3 1198,6906,9357,	
regularmente 2 44 2 1196,9355,	
controlarse 2 44 2 1195,9354,	
inicio 13 44 13 1184,1559,2581,2799,3174,3452,4232,4263,4591,5528,6993,9343,9718,	
7 9 44 9 1182,2245,3320,3450,4800,7036,7078,8113,9341,	
Child-Pugh 3 44 3 1181,3449,9340,	
Lista 1 44 1 7913,	
escala 8 44 8 1180,3448,4226,4239,4293,4532,4729,9339,	
valoración 3 44 3 1177,3445,9336,	
repetidas 3 44 3 7398,7452,7530,	
tenían 5 44 5 1175,4281,5490,5564,9334,	
observación 3 44 3 1168,3437,9327,	
absorbe 1 44 1 6458,	
comparación 3 44 3 1159,3428,9318,	
hepáticas 3 44 3 1156,3425,9315,	
adversas 13 44 13 1155,2049,2295,2310,2316,2394,2421,2460,3424,3463,3478,3535,9314,	
reacciones 12 44 12 1154,2048,2294,2315,2393,2420,2459,3423,3462,3477,3534,9313,	
elevada 4 44 4 1152,3421,3713,9311,	
incidencia 7 44 7 1150,3310,3419,7641,7774,7846,9309,	
Hipromelosa 1 44 1 7933,	
observó 10 44 10 1148,3417,7402,7447,7570,7592,7629,7814,7843,9307,	
descompensada 10 44 10 1141,1146,1193,3410,3415,5808,5823,9300,9305,9352,	
resistencias 3 44 3 1526,5797,9685,	
justificada 2 44 2 1137,9296,	
reanudación 2 44 2 1128,9287,	
determinados 2 44 2 1125,9284,	
interrumpir 2 44 2 1117,9276,	
meses 4 44 4 1114,1234,9273,9393,	
mínimo 4 44 4 1111,3172,6649,9270,	
laboratorio 6 44 6 1108,2389,2550,2778,3835,9267,	
clínico 4 44 4 1103,4172,7759,9262,	
seguimiento 10 44 10 1102,1413,3185,3238,3253,3276,5252,5313,9261,9572,	
mediante 2 44 2 1100,9259,	
periódicos 2 44 2 1099,9258,	
monitorizarse 4 44 4 1096,1513,9255,9672,	
notificó 2 44 2 1083,9242,	
24 12 44 12 1077,3215,4829,5255,5606,5614,5626,5897,6096,6379,6901,9236,	
23 3 44 3 1075,3213,9234,	
prueba 1 44 1 8055,	
adversos 2 44 2 3719,7658,	
relacionado 2 44 2 1430,9589,	
media 10 44 10 1064,2509,2699,2738,2903,3771,5545,7223,7247,9223,	
letales 2 44 2 1050,9209,	
graves 7 44 7 1048,1157,1358,3426,9207,9316,9517,	
casos 11 44 11 1045,1126,1275,1357,3052,5757,5791,9204,9285,9434,9516,	
notificado 7 44 7 1044,1274,3095,3506,5735,9203,9433,	
Leve 1 44 1 6997,	
embargo 4 44 4 1041,7363,7883,9200,	
Sin 5 44 5 1040,4426,7362,7882,9199,	
espontáneamente 2 44 2 1039,9198,	
remitir 2 44 2 1038,9197,	
parece 2 44 2 1037,9196,	
mayoría 7 44 7 1036,1081,3049,3219,4362,9195,9240,	
elevación 4 44 4 1026,1325,9185,9484,	
normalmente 4 44 4 1023,1287,9182,9446,	
asocian 4 44 4 1022,1447,9181,9606,	
potenciales 1 44 1 2155,	
post-tratamiento 9 44 9 1020,1072,3186,3277,3316,5253,5314,9179,9231,	
presentaban 2 44 2 5504,5551,	
Las 8 44 8 1018,2392,2419,2444,2458,4047,4088,9177,	
suspendido 2 44 2 1011,9170,	
comunicado 2 44 2 1001,9160,	
distribuido 2 44 2 8000,8025,	
dichas 1 44 1 6198,	
También 2 44 2 998,9157,	
supervisión 2 44 2 994,9153,	
estrecha 2 44 2 993,9152,	
deben 13 44 13 990,1194,1256,1437,1520,1877,1923,2166,9149,9353,9415,9596,9679,	
consiguiente 4 44 4 989,2083,6604,9148,	
Agencia 1 44 1 8181,	
reagudización 4 44 4 983,1003,9142,9162,	
postcomercialización 1 44 1 3458,	
riesgo 8 44 8 977,1312,1404,1867,2131,9136,9471,9563,	
mayor 11 44 11 976,1263,3319,4337,5638,7159,7262,7302,7845,9135,9422,	
cirrosis 10 44 10 972,1140,1145,1192,3409,3414,9131,9299,9304,9351,	
asignados 2 44 2 5583,5656,	
descompensación 4 44 4 967,979,9126,9138,	
rtA181V 1 44 1 3814,	
embarazadas 1 44 1 2112,	
bilirrubina 4 44 4 963,2614,2833,9122,	
perros 3 44 3 7400,7534,7817,	
concentraciones 15 44 15 960,1987,2630,2643,2658,2847,2862,3884,3899,3950,3961,6461,6857,7747,9119,	
frecuencias 2 44 2 2443,2445,	
aumento 11 44 11 957,1374,1418,3024,3071,3207,7140,7638,9116,9533,9577,	
acompañados 2 44 2 954,9113,	
general 5 44 5 953,1511,3038,9112,9670,	
semanas 31 44 31 936,1078,1576,2363,2512,2690,2702,2741,2894,2906,3216,4186,4396,4644,4758,4830,4890,5084,5256,5311,5343,5607,5615,5627,5672,5938,6057,6340,7497,9095,9237,	
aparición 10 44 10 925,1069,1352,1490,1708,7615,9084,9228,9511,9649,	
descenso 4 44 4 4013,4220,6668,6678,	
mediana 5 44 5 920,3200,6054,6337,9079,	
definió 1 44 1 4217,	
habían 3 44 3 1534,5536,9693,	
tratados 40 44 40 916,1054,1536,1637,2954,2963,2999,3008,3014,3140,3149,3190,3259,3266,3342,4308,4349,4594,4939,5016,5026,5059,5067,5138,5148,5154,5169,5177,5214,5222,5533,5621,5855,5933,5979,6177,6277,9075,9213,9695,	
séricos 2 44 2 904,9063,	
aumentar 3 44 3 896,1985,9055,	
antiviral 6 44 6 891,1216,3739,3955,9050,9375,	
iniciar 2 44 2 888,9047,	
Después 5 44 5 886,6850,7176,7281,9045,	
ALT 35 44 35 884,893,947,1445,2560,2589,2604,2788,2808,2822,2936,2981,3027,3074,3156,3210,3273,3315,4316,4500,4699,4811,4917,4969,5043,5113,5135,5196,5370,5411,5683,9043,9052,9106,9604,	
mg) 1 44 1 7795,	
transitorios 2 44 2 879,9038,	
caracterizan 2 44 2 876,9035,	
rica 1 44 1 6623,	
frecuentes 4 44 4 873,2296,2396,9032,	
relativamente 2 44 2 872,9031,	
son 4 44 4 871,2293,6567,9030,	
reagudizaciones 11 44 11 864,927,1019,1047,1071,3096,9023,9086,9178,9206,9230,	
Reagudizaciones 4 44 4 859,2915,3087,9018,	
conteniendo 1 44 1 1806,	
especiales 5 44 5 804,5462,7954,8082,8963,	
precauciones 2 44 2 803,8962,	
Advertencias 2 44 2 801,8960,	
activo 3 44 3 792,4195,8951,	
principio 2 44 2 791,8950,	
68% 1 44 1 5064,	
Hipersensibilidad 2 44 2 789,8948,	
Contraindicaciones 2 44 2 788,8947,	
insuficiencia 8 44 8 784,813,1245,6911,7135,8943,8972,9404,	
residuos 3 44 3 1550,4092,9709,	
** 2 44 2 760,8919,	
* 2 44 2 748,8907,	
72 2 44 2 746,8905,	
aumentos 12 44 12 878,944,2557,2785,2805,2933,2978,3153,3270,7771,9037,9103,	
días 6 44 6 741,763,3524,6536,8900,8922,	
linfocitos 1 44 1 7744,	
diferencias 7 44 7 3376,5430,7168,7180,7192,7273,7285,	
5-7 2 44 2 740,8899,	
DPAC** 2 44 2 735,8894,	
ó 6 44 6 733,734,5047,5870,8892,8893,	
Hemodiálisis 2 44 2 731,8890,	
detallada 1 44 1 8169,	
Cmín 1 44 1 6555,	
05 4 44 4 718,4521,4718,8877,	
PCR 15 44 15 4548,4745,4910,4962,5039,5104,5126,5190,5363,5408,5889,6085,6145,6368,6429,	
10 18 44 18 716,2562,2790,2938,2983,3158,3863,5835,6221,6535,7006,7008,7426,7679,8012,8037,8160,8875,	
15 6 44 6 702,3621,6291,7010,7012,8861,	
día* 10 44 10 692,707,714,723,730,8851,8866,8873,8882,8889,	
25 4 44 4 687,4814,7254,8846,	
30-49 2 44 2 685,8844,	
(ml/min) 5 44 5 668,6994,7056,7079,8827,	
Resistencia 8 44 8 664,1460,3984,5841,5960,6259,8823,9619,	
Aclaramiento 3 44 3 658,6989,8817,	
Baraclude* 2 44 2 657,8816,	
rigurosamente 6 44 6 654,858,1515,8813,9017,9674,	
monitorizada 4 44 4 653,857,8812,9016,	
respuesta 26 44 26 649,853,1215,1425,1517,3293,3305,4248,4268,4335,4771,4789,4841,4862,4897,4948,5091,5233,5239,5324,5350,8808,9012,9374,9584,9676,	
sustitución 2 44 2 3890,3909,	
Por 8 44 8 645,849,1743,2082,2190,5782,8804,9008,	
ligera 1 44 1 6636,	
clínicamente 5 44 5 644,848,6702,8803,9007,	
evaluadas 4 44 4 643,847,8802,9006,	
sometidas 1 44 1 7587,	
desconocida 2 44 2 1337,9496,	
sido 10 44 10 642,846,1535,1687,1763,1791,5717,8801,9005,9694,	
falanges) 1 44 1 7613,	
sugiere 2 44 2 6839,6892,	
10) 1 44 1 4290,	
(en 6 44 6 1279,1392,4806,4818,9438,9551,	
han 22 44 22 641,845,1010,1043,1273,2006,2052,2117,2224,2257,3094,3103,3129,3473,3505,4115,5734,8800,9004,9169,9202,9432,	
limitados 5 44 5 634,838,1601,8793,8997,	
8) 6 44 6 912,1091,7024,7058,9071,9250,	
extrapolación 5 44 5 631,835,7902,8790,8994,	
basados 4 44 4 628,832,8787,8991,	
están 6 44 6 627,831,1679,1784,8786,8990,	
propuestos 4 44 4 626,830,8785,8989,	
ajustes 4 44 4 623,827,8782,8986,	
Los 31 44 31 622,826,969,1239,1338,1356,1902,2113,2220,3511,3801,3902,4312,4786,4822,4834,5488,5517,5572,6023,6123,6321,6406,6550,6591,8781,8985,9128,9398,9497,9515,	
dosificación 2 44 2 614,8773,	
intervalos 4 44 4 612,1098,8771,9257,	
21 1 44 1 7579,	
aumentando 2 44 2 610,8769,	
alternativa 2 44 2 606,8765,	
guanosina 1 44 1 3596,	
disponible 4 44 4 602,1932,8174,8761,	
estuviera 2 44 2 601,8760,	
caso 8 44 8 594,1222,3508,3538,3778,6706,8753,9381,	
tabla 8 44 8 590,621,4388,4636,6258,6968,8749,8780,	
detalla 2 44 2 587,8746,	
según 3 44 3 585,2435,8744,	
solución 8 44 8 583,598,758,1934,6595,8742,8757,8917,	
(60 1 44 1 7084,	
utilizando 3 44 3 579,3841,8738,	
diaria 4 44 4 578,1897,6889,8737,	
precisan 2 44 2 1411,9570,	
(DPAC) 3 44 3 570,6960,8729,	
correspondían 1 44 1 7421,	
continua 3 44 3 569,6959,8728,	
local 1 44 1 8112,	
ambulatoria 3 44 3 568,6958,8727,	
inhibe 2 44 2 3631,3741,	
peritoneal 3 44 3 567,6957,8726,	
alcanzaban 1 44 1 3291,	
diálisis 2 44 2 566,8725,	
reducción 7 44 7 574,3057,4141,5629,5664,7598,8733,	
hemodiálisis 7 44 7 564,765,772,6943,8723,8924,8931,	
sometidos 3 44 3 562,7624,8721,	
aquéllos 2 44 2 561,8720,	
Receptores 1 44 1 1595,	
incluidos 3 44 3 560,7456,8719,	
ml/min 3 44 3 559,6836,8718,	
50 7 44 7 558,671,2676,2880,7075,8717,8830,	
experimentaron 4 44 4 3152,3269,3533,6223,	
< 27 44 27 557,715,751,2456,2597,2633,2638,2675,2679,2816,2879,2883,4343,4798,4906,4958,5035,5100,5122,5186,5359,5404,5500,5569,8716,8874,8910,	
Se 16 44 16 545,571,1704,1829,2128,2208,2628,2845,3075,5733,6157,6498,7514,7842,8704,8730,	
máximo 3 44 3 4887,5081,5340,	
creatinina 10 44 10 540,556,667,6939,6991,7185,7290,8699,8715,8826,	
disminuir 3 44 3 535,6935,8694,	
disminuye 4 44 4 533,4039,6933,8692,	
aclaramiento 11 44 11 530,537,554,6823,6930,6937,7183,7288,8689,8696,8713,	
Insuficiencia 8 44 8 527,773,807,6903,6927,8686,8932,8966,	
etnia 2 44 2 526,8685,	
sexo 4 44 4 523,3388,5440,8682,	
ajuste 4 44 4 517,818,8676,8977,	
étnico 4 44 4 512,7341,7350,8671,	
Sexo 3 44 3 509,7153,8668,	
renal"" 2 44 2 504,8663,	
lipasa 2 44 2 2660,2864,	
""Insuficiencia 2 44 2 503,8662,	
recomendaciones 2 44 2 499,8658,	
dependiendo 2 44 2 491,8650,	
ajustarse 2 44 2 490,8649,	
náuseas 5 44 5 1344,2417,2524,2752,9503,	
análogo 3 44 3 1305,3594,9464,	
La 21 44 21 487,1092,1577,1617,2311,3674,3770,4022,4135,4247,5195,6236,6472,6611,6686,6742,7134,8087,8167,8646,9251,	
edad 10 44 10 484,2164,3399,5452,7203,7216,7240,7318,7327,8643,	
función 20 44 20 481,494,521,1093,1164,1618,1974,2028,3082,3433,5438,6924,7131,7171,7276,8640,8653,8680,9252,9323,	
ajustar 10 44 10 477,547,607,778,7178,7283,8636,8706,8766,8937,	
fumarato 2 44 2 2003,5526,	
necesario 8 44 8 476,515,777,2147,3555,8635,8674,8936,	
Ancianos 3 44 3 473,7196,8632,	
seguridad 16 44 16 470,637,841,1607,2374,2490,2710,2720,2914,3330,3360,3382,7391,8629,8796,9000,	
ausencia 5 44 5 466,1280,4118,8625,9439,	
debido 9 44 9 463,1422,5792,6016,6308,7165,7270,8622,9581,	
18 5 44 5 461,3706,6683,8582,8620,	
menores 4 44 4 459,3877,6783,8618,	
anti-HIV 1 44 1 3967,	
niños 3 44 3 458,8057,8617,	
recomendado 2 44 2 454,8613,	
adolescentes 2 44 2 450,8609,	
Niños 2 44 2 448,8607,	
paciente 8 44 8 447,486,497,3546,5781,8606,8645,8656,	
apropiado 2 44 2 444,8603,	
principalmente 1 44 1 7269,	
actividades 2 44 2 2288,3635,	
sigue 2 44 2 442,8601,	
continuar 2 44 2 439,8598,	
asegurar 2 44 2 437,8596,	
probablemente 1 44 1 7837,	
858) 1 44 1 2356,	
periódica 3 44 3 435,3079,8594,	
reevaluación 2 44 2 434,8593,	
indica 2 44 2 618,8777,	
recomienda 13 44 13 432,546,572,756,816,1775,2236,3076,8591,8705,8731,8915,8975,	
años 12 44 12 430,462,5549,7221,7227,7245,7251,7323,7765,7950,8589,8621,	
prolongados 2 44 2 425,8584,	
tratamientos 2 44 2 424,8583,	
Con 2 44 2 422,8581,	
esteatosis 4 44 4 1271,1292,9430,9451,	
10-29 2 44 2 700,8859,	
negativos 11 44 11 399,1087,1825,2484,3229,4421,5072,5321,7737,8558,9246,	
4) 8 44 8 395,3122,3372,3921,5803,7026,7152,8554,	
eficacia 18 44 18 391,421,472,639,843,1604,1657,1819,4277,4541,4738,5434,6719,8550,8580,8631,8798,9002,	
basales 3 44 3 4314,4360,5694,	
pérdida 8 44 8 389,419,3913,4803,4934,4986,8548,8578,	
haya 4 44 4 386,416,8545,8575,	
HBs 4 44 4 382,412,8541,8571,	
meses) 2 44 2 377,8536,	
- 15 44 15 375,3034,3214,3797,6468,6524,6534,6654,6674,6684,6834,6873,7219,7243,8534,	
separadas 2 44 2 369,8528,	
esternón 1 44 1 7611,	
suero 2 44 2 368,8527,	
consecutivas 2 44 2 366,8525,	
muestras 3 44 3 365,4131,8524,	
anticuerpos 2 44 2 361,8520,	
detección 2 44 2 359,8518,	
ADN 27 44 27 354,906,1031,3656,3671,3729,3745,4484,4685,4903,4955,5032,5097,5119,5183,5356,5401,5666,5891,6087,6140,6370,6424,7732,8513,9065,9190,	
HBe 4 44 4 348,362,8507,8521,	
seroconversión 12 44 12 347,381,411,4921,4928,4973,4980,5375,5702,8506,8540,8570,	
cumplían 2 44 2 4767,4837,	
(pérdida 2 44 2 349,8508,	
produzca 4 44 4 345,409,8504,8568,	
administrarse 6 44 6 337,403,768,8496,8562,8927,	
positivos 7 44 7 335,4415,4570,4878,5331,5479,8494,	
En 46 44 46 332,396,592,913,937,1051,1124,1189,1503,1527,2368,2966,3123,3187,3230,3278,3537,3881,3922,3951,4209,4386,4562,4634,4937,5652,5755,5900,6966,7392,7477,7557,7585,7622,7646,7662,8491,8555,8751,9072,9096,9210,9283,9348,9662,9686,	
siguiente 6 44 6 331,591,6257,6969,8490,8750,	
cuenta 2 44 2 329,8488,	
interrupción 4 44 4 322,1238,8481,9397,	
óptima 2 44 2 317,8476,	
duración 5 44 5 316,1572,2698,2902,8475,	
desconoce 4 44 4 314,2129,2209,8473,	
Duración 4 44 4 310,2684,2888,8469,	
virológica 12 44 12 650,854,1518,4179,4336,4368,4792,4842,4863,8809,9013,9677,	
2) 15 44 15 309,508,544,825,1645,1964,2081,4536,4733,6728,7020,8468,8667,8703,8984,	
copias/ml 12 44 12 4328,4494,4693,4908,4960,5037,5102,5124,5188,5361,5406,5677,	
apartado 25 44 25 307,393,542,823,910,1089,1592,1643,1740,1809,1962,2079,2125,3120,3370,3919,5801,6726,7150,8466,8552,8701,8982,9069,9248,	
(E433) 1 44 1 7938,	
comida) 2 44 2 305,8464,	
Ishak 4 44 4 4447,4462,4659,4670,	
después 11 44 11 302,769,1115,1235,3088,3484,4183,8461,8928,9274,9394,	
horas 13 44 13 295,301,747,3622,6471,6657,6664,6875,6902,6946,8454,8460,8906,	
(más 2 44 2 292,8451,	
30°C 1 44 1 7964,	
ayunas 2 44 2 291,8450,	
limita 3 44 3 1170,3439,9329,	
[LVDr]) 2 44 2 278,8437,	
resistencia 21 44 21 274,1482,1499,1541,3809,4036,4099,4123,4136,5850,5917,5953,5987,6188,6201,6237,6285,8433,9641,9658,9700,	
confieren 10 44 10 273,1481,3808,4035,4098,4122,5916,5952,8432,9640,	
mutaciones 9 44 9 271,1470,1585,3806,4588,6127,6410,8430,9629,	
144 6 44 6 1575,5937,5968,6217,6247,6268,	
durante 47 44 47 264,426,928,995,1109,1217,1232,1247,1566,1625,2140,2239,2357,2507,2736,2916,2928,2973,3028,3084,3183,3274,3479,3519,4780,4828,4885,5079,5338,5543,5605,5616,5883,6052,6090,6335,6373,7466,7492,8423,8585,9087,9154,9268,9376,9391,9406,	
107 1 44 1 2362,	
viremia 3 44 3 263,5505,8422,	
indicios 5 44 5 261,3550,7500,7699,8420,	
decir 2 44 2 259,8418,	
(es 2 44 2 258,8417,	
resistentes 17 44 17 255,1466,1711,2714,2970,3234,3783,3997,4559,4574,5326,6160,6250,6273,6722,8414,9625,	
alcanzar 1 44 1 6852,	
alimentos 4 44 4 253,6659,6698,8412,	
equilibrio 1 44 1 6814,	
HBsAg 2 44 2 4930,4982,	
o 66 44 66 251,269,297,378,383,413,524,565,732,793,965,1250,1332,1564,1640,1650,1671,1918,1976,2023,2061,2352,3067,3175,3397,3813,3936,3981,4032,4061,4066,4071,4621,4778,4810,4846,5449,5600,5898,6097,6112,6151,6380,6395,6434,6633,6759,6778,6914,7117,7509,7818,8410,8428,8456,8537,8542,8572,8683,8724,8891,8952,9124,9409,9491,9723,	
recomendada 4 44 4 240,281,8399,8440,	
carácter 2 44 2 1510,9669,	
dosis 49 44 49 239,280,479,488,501,519,549,577,609,625,750,780,821,829,1896,2122,3526,5858,6035,6505,6518,6562,6578,6821,6829,6951,6978,7112,7397,7418,7451,7529,7677,8008,8033,8398,8439,8638,8647,8660,8678,8708,8736,8768,8784,8909,8939,8980,8988,	
Pacientes 21 44 21 232,254,660,1138,1673,1779,3407,4870,4876,5070,5325,5329,5463,5705,5804,5978,6276,8391,8413,8819,9297,	
día 20 44 20 231,249,289,678,684,699,2506,2735,4611,4630,5596,5832,5840,6543,8390,8408,8448,8837,8843,8858,	
vez 35 44 35 229,247,287,676,682,690,697,705,712,721,728,1252,2504,2733,4503,4609,4628,4702,5201,5594,5830,5838,6541,8388,8406,8446,8835,8841,8849,8856,8864,8871,8880,8887,9411,	
oral 10 44 10 227,584,599,759,1935,6596,8386,8743,8758,8918,	
vía 3 44 3 226,2021,8385,	
tomarse 2 44 2 224,8383,	
experiencia 2 44 2 213,8372,	
médico 2 44 2 211,8370,	
iniciado 2 44 2 208,8367,	
debe 31 44 31 206,223,326,336,402,489,651,767,855,1095,1512,1620,1747,1850,2039,2138,2193,3543,4138,5787,8365,8382,8485,8495,8561,8648,8810,8926,9014,9254,9671,	
El 14 44 14 204,2487,2717,3820,4154,4761,6527,6822,6876,7257,7307,7796,7894,8363,	
x 11 44 11 2791,2826,2852,2867,2939,2984,4318,7994,8013,8019,8038,	
efecto 6 44 6 2176,2285,4105,7200,7420,7887,	
administración 11 44 11 203,1296,2537,2765,6515,6539,6612,6767,6887,8362,9455,	
forma 5 44 5 201,3610,5493,7442,8360,	
Posología 4 44 4 199,655,8358,8814,	
1) 9 44 9 196,1594,1742,1811,7060,7064,7085,7087,8355,	
combinada 2 44 2 6050,6333,	
presentó 5 44 5 2556,2586,2784,2804,5701,	
secciones 2 44 2 191,8350,	
descender 2 44 2 901,9060,	
(ver 30 44 30 190,306,392,498,541,822,909,1088,1591,1642,1739,1808,1961,2078,2124,3119,3369,3918,5800,5939,6725,7149,8349,8465,8551,8657,8700,8981,9068,9247,	
lamivudina 62 44 62 189,257,268,277,666,1468,1484,1508,1539,1807,1997,2059,2353,2378,2716,2965,2972,3010,3151,3236,3268,3354,3785,3933,3999,4125,4411,4519,4561,4576,4596,4624,4647,4716,4941,5028,5069,5140,5156,5179,5224,5277,5307,5328,5516,5542,5580,5955,6176,6195,6252,6275,6724,8348,8416,8427,8436,8825,9627,9643,9667,9698,	
resistente 5 44 5 187,1506,4156,8346,9665,	
(< 7 44 7 1845,4492,4691,5046,5990,5993,5996,	
nucleósidos 28 44 28 181,237,670,1062,1300,1320,1388,2481,2927,3134,3198,3576,3975,4311,4352,4380,4430,4875,5908,5977,6713,8340,8396,8829,9221,9459,9479,9547,	
previo 21 44 21 179,235,663,1060,2479,2925,3132,3196,4378,4428,4873,5540,5867,5906,5975,6193,6711,8338,8394,8822,9219,	
negativa 2 44 2 173,8332,	
HBeAg 33 44 33 171,175,334,351,398,1086,1824,3228,4354,4417,4423,4511,4572,4708,4805,4808,4820,4877,4923,4975,5071,5320,5330,5377,5478,5483,5704,8330,8334,8493,8510,8557,9245,	
positiva 2 44 2 169,8328,	
VHB 47 44 47 168,356,908,1033,1476,1871,2183,2207,3368,3604,3647,3673,3683,3747,3766,3782,3994,4152,4155,4324,4342,4486,4687,4794,4797,4905,4957,5034,5099,5121,5185,5358,5403,5508,5635,5668,5893,6089,6142,6372,6426,7108,8327,8515,9067,9192,9635,	
pacientes 161 44 161 163,176,183,333,397,552,782,811,899,915,938,970,1008,1053,1085,1143,1162,1173,1190,1240,1391,1410,1465,1532,1661,1690,1718,1751,1823,1835,1854,1903,2044,2331,2476,2555,2601,2642,2657,2683,2713,2783,2820,2861,2887,2922,2953,2962,2969,2998,3007,3013,3101,3126,3139,3148,3189,3227,3233,3245,3258,3290,3323,3338,3364,3403,3412,3431,3442,4133,4251,4280,4306,4347,4365,4375,4414,4523,4558,4569,4586,4593,4720,4807,4819,4823,4835,4857,4938,4995,5015,5025,5058,5137,5147,5213,5227,5263,5292,5303,5319,5381,5422,5457,5477,5489,5532,5563,5573,5654,5691,5700,5720,5743,5819,5854,5903,5932,5972,6045,6070,6078,6124,6173,6222,6249,6272,6353,6361,6407,6708,6721,6909,6922,6984,7148,7313,8322,8335,8342,8492,8556,8711,8941,8970,9058,9074,9097,9129,9167,9212,9244,9302,9321,9332,9349,9399,9550,9569,9624,9691,	
animales 3 44 3 2116,2223,7491,	
obtenidos 2 44 2 161,8320,	
clínicos 11 44 11 160,1199,2322,3281,3471,3838,4053,4191,5846,8319,9358,	
ensayos 20 44 20 159,2321,2370,2920,2967,3124,3231,3280,3395,3470,4190,4212,4399,5447,5845,5901,5970,6243,6270,8318,	
Ninguna 1 44 1 8085,	
datos 13 44 13 157,468,633,837,1600,1654,1816,2103,2173,8316,8627,8792,8996,	
basa 6 44 6 155,2318,2492,2722,4174,8314,	
indicación 2 44 2 153,8312,	
Esta 6 44 6 152,1167,3436,7441,8311,9326,	
fibrosis 8 44 8 151,4244,4255,4445,4456,4657,4666,8310,	
histología 2 44 2 4525,4722,	
y/o 4 44 4 150,4068,5924,8309,	
inflamación 3 44 3 148,7403,8307,	
histológicas 2 44 2 146,8305,	
pruebas 11 44 11 145,387,417,1106,2387,2548,2776,8304,8546,8576,9265,	
elevados 2 44 2 143,8302,	
persistentemente 2 44 2 142,8301,	
sérica 10 44 10 141,885,894,948,964,8300,9044,9053,9107,9123,	
(ALT) 2 44 2 140,8299,	
aminotransferasa 2 44 2 139,8298,	
alanina 2 44 2 138,8297,	
(19%) 1 44 1 6292,	
niveles 15 44 15 136,882,903,1029,4313,5030,5181,5399,5693,6854,7885,8295,9041,9062,9188,	
mayores 1 44 1 7428,	
activa 6 44 6 135,149,1983,3611,8294,8308,	
vírica 3 44 3 134,4208,8293,	
45 3 44 3 1172,3441,9331,	
replicación 4 44 4 133,4162,4207,8292,	
fertilidad 1 44 1 7505,	
evidencia 3 44 3 131,4205,8290,	
compensada 8 44 8 129,942,1166,3435,4385,8288,9101,9325,	
94% 1 44 1 5094,	
hepática 35 44 35 128,774,785,941,968,980,1094,1165,1210,1246,1293,1370,1408,3083,3434,4283,4384,5807,5822,6904,6912,6925,8287,8933,8944,9100,9127,9139,9253,9324,9369,9405,9452,9529,9567,	
enfermedad 10 44 10 127,940,1407,4282,4383,5806,5821,8286,9099,9566,	
adultos 4 44 4 125,1795,4199,8284,	
(VHB) 2 44 2 123,8282,	
B 23 44 23 122,186,220,869,1017,1123,1134,1207,1458,1722,2334,3113,4202,6987,8281,8345,8379,9028,9176,9282,9293,9366,9617,	
hepatitis 34 44 34 121,185,219,862,868,986,1006,1016,1122,1133,1206,1399,1457,1648,1669,1721,2333,3099,3112,4201,6986,8280,8344,8378,9021,9027,9145,9165,9175,9281,9292,9365,9558,9616,	
virus 9 44 9 118,1475,1666,3109,3802,3996,4086,8277,9634,	
crónica 11 44 11 115,221,870,1459,1723,2335,4203,8274,8380,9029,9618,	
infección 8 44 8 114,165,1720,1726,1769,2202,8273,8324,	
tratamiento 124 44 124 111,178,205,216,234,266,312,319,324,339,401,441,662,890,930,997,1013,1059,1119,1130,1186,1219,1228,1249,1316,1427,1561,1627,1682,1699,1733,1766,1787,1862,2241,2337,2430,2478,2497,2583,2686,2692,2727,2801,2890,2896,2918,2924,2930,2975,3030,3045,3086,3092,3106,3116,3131,3195,3283,3299,3454,4188,4234,4372,4377,4427,4760,4762,4785,4833,4851,4868,4872,4882,4992,5000,5076,5194,5207,5335,5385,5426,5539,5588,5660,5728,5866,5885,5905,5974,6060,6092,6192,6211,6343,6375,6710,8270,8337,8364,8375,8393,8425,8471,8478,8483,8498,8560,8600,8821,9049,9089,9156,9172,9218,9278,9289,9345,9378,9387,9408,9475,9586,9720,	
indicado 2 44 2 108,8267,	
está 6 44 6 107,453,5810,8173,8266,8612,	
compensada) 1 44 1 4284,	
Baraclude 13 44 13 106,222,451,582,757,1937,2136,2243,8265,8381,8610,8741,8916,	
terapéuticas 2 44 2 105,8264,	
Indicaciones 2 44 2 104,8263,	
	"4 2 44 2 102,8261,	
pulmonares 2 44 2 7777,7831,	
CLÍNICOS 2 44 2 101,8260,	
DATOS 3 44 3 100,7909,8259,	
4 45 44 45 99,192,193,197,394,786,799,800,824,911,933,1090,1940,2096,2244,2307,3033,3121,3371,3500,3920,4260,5547,5802,6568,6727,6945,7007,7013,7151,7496,7780,7952,8258,8351,8352,8356,8553,8945,8958,8959,8983,9070,9092,9249,	
" 4 44 4 98,3563,8257,9725,	
""1611"" 1 44 1 94,	
cara 2 44 2 92,8251,	
espontáneas 2 44 2 865,9024,	
grabado 2 44 2 89,8248,	
""BMS"" 2 44 2 88,8247,	
blanquecino 1 44 1 86,	
70% 1 44 1 6497,	
blanco 1 44 1 84,	
triangular 2 44 2 83,8244,	
Comprimido 2 44 2 82,8243,	
(comprimido) 2 44 2 81,8242,	
recubierto 2 44 2 78,8239,	
	"Comprimido 2 44 2 77,8238,	
FARMACÉUTICA 2 44 2 76,8237,	
FORMA 2 44 2 75,8236,	
3 22 44 22 74,374,709,787,2591,2647,2662,2851,2866,3634,6218,6572,7011,7053,7072,7387,7945,8002,8235,8533,8868,8946,	
6 22 44 22 72,376,1113,1233,2097,6533,6629,7015,7051,7074,7076,7908,7939,7944,7951,7983,8079,8080,8233,8535,9272,9392,	
sección 4 44 4 71,506,8232,8665,	
mostraron 2 44 2 3911,4366,	
ver 3 44 3 70,5050,8231,	
competir 1 44 1 3624,	
excipientes 5 44 5 69,798,7915,8230,8957,	
completa 2 44 2 67,8228,	
lista 2 44 2 66,8227,	
consultar 2 44 2 64,8225,	
Para 8 44 8 63,320,1415,1927,5225,8224,8479,9574,	
renal 22 44 22 495,528,808,814,1212,1372,1619,1975,2022,2029,6824,6928,7132,7136,7172,7277,8654,8687,8967,8973,9371,9531,	
lactosa 4 44 4 62,1893,1939,8223,	
acerca 1 44 1 2174,	
120 2 44 2 58,1889,	
Excipientes 2 44 2 54,8216,	
monohidrato) 2 44 2 53,8215,	
(como 2 44 2 52,8214,	
entecavir 133 44 133 51,532,766,918,1056,1188,1302,1501,1543,1563,1609,1629,1659,1684,1713,1749,1789,1821,1864,1954,2014,2031,2057,2088,2109,2178,2211,2229,2264,2279,2339,2346,2376,2408,2432,2499,2695,2729,2899,2956,3001,3016,3118,3142,3192,3261,3285,3332,3362,3384,3456,3483,3590,3715,3740,3775,3819,3827,3887,3901,3917,3944,3959,4021,4038,4043,4077,4101,4111,4406,4605,4884,5018,5061,5078,5150,5171,5216,5267,5296,5337,5387,5436,5535,5590,5623,5640,5662,5714,5750,5785,5826,5860,5919,5935,6040,6062,6162,6179,6213,6239,6345,6456,6618,6736,6753,6769,6795,6842,6860,6932,6975,7098,7145,7208,7339,7361,7464,7489,7567,7671,7687,7692,8213,8691,8925,9077,9215,9347,9461,9660,9702,9722,	
contiene 8 44 8 46,57,1888,7992,8059,8067,8209,8219,	
comprimido 5 44 5 45,56,7918,8208,8218,	
completamente 1 44 1 1590,	
	Cada 2 44 2 44,8207,	
CUANTITATIVA 2 44 2 43,8206,	
Y 2 44 2 42,8205,	
CUALITATIVA 2 44 2 41,8204,	
COMPOSICIÓN 2 44 2 40,8203,	
2 31 44 31 39,198,294,300,423,2576,2606,2617,2623,2634,2825,3062,3164,4222,4317,6311,6452,6569,6585,6640,6884,7047,7070,7123,7791,7940,7949,8202,8357,8453,8459,	
película 5 44 5 38,80,8064,8201,8241,	
96% 1 44 1 5166,	
recubiertos 5 44 5 36,7997,8022,8062,8199,	
comprimidos 8 44 8 35,6592,7996,8015,8021,8040,8061,8198,	
mg 52 44 52 34,49,60,245,285,674,680,688,695,703,710,719,726,738,744,754,1891,1901,2502,2731,3531,4607,4626,5592,5828,5836,5864,5873,6038,6526,6566,6581,6616,6982,7439,7789,8197,8211,8221,8404,8444,8833,8839,8847,8854,8862,8869,8878,8885,8897,8903,8913,	
5 56 44 56 33,48,59,195,244,308,507,543,673,694,737,743,753,935,1593,1644,1741,1810,1890,1900,1941,1963,2080,2126,2341,2501,2635,3035,3564,5562,5863,6451,6467,6470,6565,6588,6615,6656,7009,7032,7034,7386,7436,7788,7984,8354,8403,8467,8666,8702,8832,8853,8896,8902,8912,9094,	
UB8 1 44 1 8130,	
	Baraclude 2 44 2 31,8195,	
MEDICAMENTO 3 44 3 30,3569,8194,	
interrumpirse 2 44 2 1314,9473,	
NOMBRE 2 44 2 28,8192,	
1 56 44 56 26,27,73,103,284,679,725,2329,2347,2730,3571,4129,4197,4502,4606,4701,4813,5049,5200,5482,5591,5827,5871,5989,5992,5995,6008,6037,6130,6227,6414,6469,6523,6525,6580,6655,6981,7005,7068,7438,7467,7553,7794,7912,7995,8014,8020,8039,8191,8196,8210,8234,8262,8443,8838,8884,	
alcanzadas 5 44 5 7431,7474,7540,7582,7783,	
PRODUCTO 1 44 1 25,	
DEL 4 44 4 24,29,8165,8193,	
grupo 3 44 3 511,5658,8670,	
CARACTERÍSTICAS 1 44 1 23,	
LAS 1 44 1 22,	
DE 9 44 9 21,3567,8115,8118,8136,8138,8148,8152,8162,	
RESUMEN 1 44 1 20,	
O 1 44 1 19,	
absorción 1 44 1 6652,	
TÉCNICA 1 44 1 18,	
FICHA 1 44 1 17,	
tuvo 2 44 2 1570,3717,	
ocasiones 2 44 2 1284,9443,	
información 3 44 3 14,1832,8168,	
Toda 1 44 1 12,	
medicamento 8 44 8 11,16,1887,1926,3466,6694,8090,8172,	
Basica 1 44 1 9,	
células/mm3 1 44 1 5559,	
	Información 1 44 1 8,	
P 1 44 1 7,	
CON 1 44 1 6,	
RECUB 1 44 1 5,	
COMPRIMIDOS 1 44 1 4,	
ciegos 1 44 1 4849,	
30 3 44 3 3,7993,8060,	
5MG 1 44 1 2,	
demostración 1 44 1 4169,	
0 53 44 53 1,32,47,243,672,686,693,701,708,717,724,736,742,752,1899,2340,2500,3686,3756,3791,3795,3798,3859,4326,4520,4717,4799,5648,5862,5872,6004,6006,6466,6522,6564,6571,6587,6614,6662,6964,7435,7787,8402,8831,8845,8852,8860,8867,8876,8883,8895,8901,8911,	
Entre 1 44 1 3011,	
BARACLUDE 1 44 1 0,	
